Approval · Notice of Compliance 3002 · 1998
ORAFEN: Notice of Compliance 3002
Issued November 12, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3002
- Date
- November 12, 1998
- Company
- Technilab Pharma Inc.Mirabel, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Nonsteroidal anti-inflammatory analgesic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORAFEN | Not yet assigned | — |
Medicinal ingredients
- KETOPROFEN 100 MG per SUP